Close

Aegis Capital Starts Revance Therapeutic (RVNC) at Buy; Likes Botulinum Opportunity

Go back to Aegis Capital Starts Revance Therapeutic (RVNC) at Buy; Likes Botulinum Opportunity
REVANCE THERAP (NASDAQ: RVNC) Delayed: 3.78 -0.01 (0.26%)
Previous Close $3.79    52 Week High $41.12 
Open $3.80    52 Week Low $12.35 
Day High $3.87    P/E N/A 
Day Low $3.71    EPS $-27.14 
Volume 1,647,560